Anika Bilal MD
Post-Doctoral Research Scientist, AdventHealth Translational Research Institute, Orlando, FloridaAnika Bilal, MD, is a postdoctoral research scientist at AdventHealth Research Institute (AHRI) in Orlando, Florida. She earned her medical degree (MD) from Lahore, Pakistan. After practicing internal medicine for 11 years in Pakistan, Dr. Bilal joined the diabetes team at AdventHealth Translational Research Institute, Orlando, Florida. Her research focuses on hypoglycemia and impaired awareness of hypoglycemia in type 1 diabetes with special interest in role of latest diabetes technology in preventing diabetic complications. Another area of her research interest includes the role of adjunctive diabetes medications in people with type 1 diabetes and the effects of newer antihyperglycemic drugs in older adults with type 2 diabetes.
Disclosures
Dr. Bilal has no relevant disclosures.Recent Contributions to PracticeUpdate:
- Real-World Effectiveness of Oral Semaglutide in Adults and Older Individuals With Type 2 Diabetes
- Real-World Impact of isCGM With Alarms on Hypoglycemia and Its Recognition in Patients With Type 1 Diabetes
- Effectiveness and Safety of Automated Insulin Delivery Compared With Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting